Following a successful pilot programme, the world’s first WHO-recommended malaria vaccines will soon be administered through routine immunisation programmes across Africa, beginning with Cameroon on Monday, 22 January 2024.
This press briefing will provide information on this historic milestone, including updates on the scale of the roll out in 2024, plans to introduce a second approved vaccine later this year and how countries are preparing for widespread immunisation.
Speakers from Gavi, the Vaccine Alliance, Africa CDC, the World Health Organization, UNICEF, and Value Health Africa will be in attendance.
Speakers, in order of appearance:
- Aurélia Nguyen, Chief Programme Officer, Gavi
- Dr Mohammed Abdulaziz, Head of Disease Control and Prevention, Africa
- Kate O’Brien, Director, Department of immunization, vaccines and biologicals, World Health Organization
- Andrew Jones, Principal Advisor in UNICEF Supply Division’s Vaccine Centre
- Mbianke Livancliff, Senior Immunization Officer, Value Health Africa (NGO improving community health in Cameroon and Africa at large)
- Dr Dorothy Achu, Regional Malaria Adviser, WHO Regional Office for Africa
LOGISTICS
- Please RSVP your attendance to media@gavi.org by 10:00 CET on Friday, 19 January 2024
- Journalists who wish to send questions in advance, can email media@gavi.org
- When logging in, please make sure your Name + Outlet are clearly visible
- For any follow-ups and access to a recording after the briefing, contact the Gavi media team (media@gavi.org)